Lee, Jimmy Tsz Hang https://orcid.org/0000-0003-1208-8356
Barnett, Sam N. https://orcid.org/0000-0002-8968-4319
Roberts, Kenny https://orcid.org/0000-0001-6155-0821
Ashwin, Helen https://orcid.org/0000-0003-1029-0032
Milross, Luke
Cho, Jae-Won
Huseynov, Alik
Woodhams, Benjamin https://orcid.org/0000-0003-2801-5733
Aivazidis, Alexander
Li, Tong https://orcid.org/0000-0002-8240-4476
Majo, Joaquim
Chaves, Patricia https://orcid.org/0000-0003-1364-0130
Lee, Michael https://orcid.org/0000-0002-0186-4439
Miranda, Antonio M. A. https://orcid.org/0000-0003-4281-614X
Jablonska, Zuzanna https://orcid.org/0000-0002-0510-957X
Arena, Vincenzo
Hanley, Brian
Osborn, Michael
Uhlmann, Virginie https://orcid.org/0000-0002-2859-9241
Xu, Xiao-Ning https://orcid.org/0000-0003-3076-6712
McLean, Gary R.
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Randi, Anna M. https://orcid.org/0000-0002-0729-211X
Filby, Andrew
Kaye, Paul M. https://orcid.org/0000-0002-8796-4755
Fisher, Andrew J. https://orcid.org/0000-0003-4822-7223
Hemberg, Martin https://orcid.org/0000-0001-8895-5239
Noseda, Michela https://orcid.org/0000-0002-9553-5029
Bayraktar, Omer Ali https://orcid.org/0000-0001-6055-277X
Funding for this research was provided by:
Wellcome Trust (WT206194, 220540/Z/20/A)
Article History
Received: 13 February 2024
Accepted: 21 January 2025
First Online: 10 March 2025
Competing interests
: In the past 3 years, S.A.T. has consulted for or been a member of scientific advisory boards (SABs) at Qiagen, OMass Therapeutics, Xaira Therapeutics and ForeSite Labs, and a non-executive director of 10x Genomics. She is a co-founder and equity holder of TransitionBio and Ensocell, and a part-time employee at GSK. The remaining authors declare no competing interests.